An oncology patent pool for combination trials across companies
Companies would put their cancer drugs into a shared licensing pool so that any qualified investigator can test combinations of drugs from different owners under one standard agreement, with royalties split by a fixed formula.
A voluntary pool, administered by a neutral body on the model of the Medicines Patent Pool and the MPEG patent pools, in which participating companies grant a standard non-exclusive licence for their approved and late-stage oncology agents to be used in combination trials sponsored by academic groups, non-profits or other pool members, with pre-agreed terms for drug supply, data rights, publication and downstream royalty sharing if a combination is approved. Today each combination requires a bespoke negotiation that can take longer than the trial; pooled terms cut that to weeks. Regulators would recognise pool trials as acceptable for combination labelling.
- Secrecy and intellectual property block collaboration · Companies with complementary drugs rarely test them together, and data that could answer questions stays locked up.
- Too many combinations to test · There are thousands of possible drug pairs and sequences. Trials can test a few dozen a year.
Pages like this
not linked directly; found by shared links- IdeaA neutral platform trial for radiotherapy plus immunotherapy combinations
Shares A permanent neutral non-profit sponsor for multi-company platform trials, Radiotherapy + immunotherapy, Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA universal material transfer agreement with a thirty-day default
Shares A regulator-endorsed standard contract for inter-company combination trials, Secrecy and intellectual property block collaboration.
- IdeaA shared library of pooled control arms to shrink and speed future trials
Shares A permanent neutral non-profit sponsor for multi-company platform trials, Secrecy and intellectual property block collaboration.
- IdeaA patent pool for combination method-of-use claims
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA single oncology trial data trust with mandatory deposit within eighteen months
Shares An antitrust safe harbour for cross-company combination trials and data pooling, Secrecy and intellectual property block collaboration.
- IdeaEvery approved cancer drug ships with a public combination-readiness data pack
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA standard cross-company combination agreement that takes weeks, not years, to sign
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
- IdeaA publicly held library of investigational drugs available for academic combination trials
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.